Lawrenceville, GANCT07611214Now EnrollingIRB Ready

Lupus Nephritis Clinical Trial in Lawrenceville, GA

Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in Lawrenceville. Study-provided care at no cost to qualified participants.

Sponsored by Aurinia Pharmaceuticals Inc.

Quick Self-Assessment

See if you qualify for this Lawrenceville location

Preparing your pre-screening questions…

Expert Care in Lawrenceville

Access lupus nephritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lupus nephritis treatment provided free

Apply for This Lawrenceville Location

Check if you qualify for this lupus nephritis clinical trial in Lawrenceville, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lawrenceville

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lawrenceville site if eligible
  4. 4Begin participation

About This Lupus Nephritis Study in Lawrenceville

The goal of this clinical study is to assess the efficacy and safety of LUPKYNIS® in combination with belimumab, obinutuzumab or anifrolumab at inducing rapid renal response in patients with lupus nephritis (LN).

Sponsor: Aurinia Pharmaceuticals Inc.

Who Can Participate

Inclusion Criteria

Adults 18-75 years old
Diagnosed with biopsy-proven lupus nephritis (LN) according to the 2003 International Society of Nephrology (ISN) / Renal Pathology Society (RPS) (class III, class IV, class III/V or class IV/V)
Urine protein-to-creatine ratio (UPCR) ≥0.5 g/g and \<5.0 g/g from a first morning void (FMV) urine sample
Estimated glomerular filtration rate (eGFR) of ≥45 mL/min/1.73 m2
Concomitant biologic:
Patients on the belimumab or anifrolumab treatment regimens are receiving belimumab or anifrolumab (as applicable) prior to Screening or will initiate belimumab or anifrolumab (as applicable) on or before Day 1.
Patients on the obinutuzumab treatment regimen must have received at least 2 administrations of obinutuzumab prior to Screening.
Willing to take mycophenolic acid analog (MPAA), either by continuing current MPAA therapy or by initiating it on or before Day 1
Willing to take corticosteroids, either by continuing current corticosteroids (prednisone \[or equivalent\]) or by initiating on or before Day 1 Key

Exclusion Criteria

Any B cell targeted therapy except for the concomitant biologics (belimumab and obinutuzumab) within 1 year prior to Screening unless demonstration of B cell count within the normal range
Cyclophosphamide or any calcineurin inhibitor other than voclosporin (eg, cyclosporine and tacrolimus) within 3 months prior to Screening
Any other immunosuppressive therapy except for the concomitant drugs (anifrolumab, MPAAs and oral prednisone \[or equivalent\]) and immunosuppressive agents used to treat a patient's underlying systemic lupus erythematosus (SLE), including, but not limited to, the examples below, within 30 days or 5 half-lives, whichever is longer, prior to Screening:
Anti-tumor necrosis factor (TNF) therapy (eg, adalimumab, etanercept, infliximab)
Anti-interleukin therapy (eg, risankizumab, secukinumab, ixekizumab, ustekinumab, guselkumab, tocilizumab, dupilumab)
T cell costimulation modulator (eg, abatacept)
Intravenous immunoglobulin (IVIg)
Janus kinase (JAK) inhibitors (eg, upadacitinib)
Pregnant, breastfeeding or intending to become pregnant during the Study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lawrenceville?

Yes, this clinical trial (NCT07611214) has an active research site in Lawrenceville, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lupus Nephritis Treatment Options in Lawrenceville, GA

If you're searching for lupus nephritis treatment options in Lawrenceville, GA, this clinical trial (NCT07611214) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lawrenceville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lupus nephritis clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in Lawrenceville, GA

See all lupus clinical trials recruiting in Lawrenceville — not just this study.

Browse Lupus Trials in Lawrenceville →

Browse More Trials by Condition

Lupus TrialsPulmonary Hypertension TrialsSystemic Lupus Erythematosus TrialsLupus Nephritis TrialsAll Conditions →

Ready to Join in Lawrenceville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lawrenceville, GA